substance p has been researched along with Craniofacial Pain in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Jasim, H | 1 |
Huang, CL; Liao, DQ; Lin, J; Liu, F; Liu, MK; Shen, JF; Song, N; Wang, H; Zhang, YY; Zhou, C | 1 |
Anderson, EM; Bokrand-Donatelli, Y; Caudle, RM; Mustafa, G; Neubert, JK | 1 |
Chou, LW; Hong, CZ; Hsieh, YL; Yang, CC; Yang, SA | 1 |
Dong, H; Geng, X; Lu, X; Yu, H; Zeng, Y; Zhang, L | 1 |
Ambalavanar, R; Dessem, D | 1 |
Harano, N; Hidaka, K; Inenaga, K; Kai, A; Nakanishi, O; Ono, K | 1 |
Caudle, RM; King, C; Neubert, JK; Nolan, TA; Suckow, SK; Vierck, CJ | 1 |
Chung, JW; Chung, SC; Jang, MU; Kho, HS; Park, JW | 1 |
Chichorro, JG; Martini, AC; Rae, GA; Teodoro, FC; Tronco Júnior, MF; Zampronio, AR | 1 |
Kaneyama, K; Miyamaru, M; Nishimura, M; Segami, N; Suzuki, T | 1 |
Maidment, NT; Matsuka, Y; Neubert, JK; Spigelman, I | 1 |
Hersh, EV; Ochs, HA; Pertes, RA | 1 |
Appelgren, A; Appelgren, B; Kopp, S; Lundeberg, T; Theodorsson, E | 1 |
Abu-Bakra, M; Jones, NS | 1 |
Kopp, S | 1 |
Shibutani, T | 1 |
3 review(s) available for substance p and Craniofacial Pain
Article | Year |
---|---|
Emerging peripheral receptor targets for deep-tissue craniofacial pain therapies.
Topics: Acid Sensing Ion Channels; Calcitonin Gene-Related Peptide; Facial Pain; Humans; Neurons, Afferent; Neuropeptides; Nociceptors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X3; Sodium Channel Blockers; Sodium Channels; Substance P; Trigeminal Nerve; TRPV Cation Channels | 2009 |
Topical capsaicin-pharmacology and potential role in the treatment of temporomandibular pain.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Chronic Disease; Facial Pain; Humans; Nerve Fibers; Substance P; Temporomandibular Joint Disorders | 1994 |
Neuroendocrine, immune, and local responses related to temporomandibular disorders.
Topics: Arthritis; Calcitonin Gene-Related Peptide; Dinoprostone; Facial Pain; Fibromyalgia; Humans; Hyperalgesia; Inflammation Mediators; Interleukin-1; Leukotriene B4; Masseter Muscle; Neuroimmunomodulation; Neuropeptide Y; Neuropeptides; Neurosecretory Systems; Open Bite; Serotonin; Substance P; Synovial Fluid; Temporomandibular Joint Disorders; Tumor Necrosis Factor-alpha | 2001 |
1 trial(s) available for substance p and Craniofacial Pain
Article | Year |
---|---|
Does stimulation of nasal mucosa cause referred pain to the face?
Topics: Administration, Intranasal; Adult; Epinephrine; Facial Pain; Female; Humans; Male; Nasal Cavity; Nasal Mucosa; Pain Measurement; Pressure; Reference Values; Severity of Illness Index; Substance P | 2001 |
13 other study(ies) available for substance p and Craniofacial Pain
Article | Year |
---|---|
Topical review - salivary biomarkers in chronic muscle pain.
Topics: Biomarkers; Brain-Derived Neurotrophic Factor; Calcitonin Gene-Related Peptide; Facial Pain; Glutamic Acid; Humans; Myalgia; Nerve Growth Factor; Substance P | 2023 |
Activation of the RAS/B-RAF-MEK-ERK pathway in satellite glial cells contributes to substance p-mediated orofacial pain.
Topics: Animals; Extracellular Signal-Regulated MAP Kinases; Facial Pain; MAP Kinase Signaling System; Neuroglia; Rats; Rats, Sprague-Dawley; Substance P | 2020 |
Anti-nociceptive effect of a conjugate of substance P and light chain of botulinum neurotoxin type A.
Topics: Analgesics; Animals; Antineoplastic Agents, Phytogenic; Botulinum Toxins, Type A; Cells, Cultured; Conditioning, Operant; Facial Pain; Female; Hot Temperature; Immunohistochemistry; Male; Mice; Mice, Hairless; Neuralgia; Neurons; Paclitaxel; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Reward; Substance P; Synaptosomal-Associated Protein 25 | 2013 |
Fluence-dependent effects of low-level laser therapy in myofascial trigger spots on modulation of biochemicals associated with pain in a rabbit model.
Topics: Animals; beta-Endorphin; Cyclooxygenase 2; Facial Pain; Ganglia, Spinal; Lasers, Semiconductor; Low-Level Light Therapy; Male; Muscle, Skeletal; Rabbits; Substance P; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Substance P expression in the distal cerebrospinal fluid-contacting neurons and spinal trigeminal nucleus in formalin-induced the orofacial inflammatory pain in rats.
Topics: Animals; Facial Pain; Formaldehyde; Immunohistochemistry; Inflammation; Injections, Subcutaneous; Male; Microscopy, Immunoelectron; Neurons; Pain Measurement; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Substance P; Trigeminal Nucleus, Spinal | 2009 |
Differences between orofacial inflammation and cancer pain.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcitonin Gene-Related Peptide; Carcinoma 256, Walker; Disease Models, Animal; Facial Neoplasms; Facial Pain; Galanin; Hot Temperature; Hyperalgesia; Indomethacin; Inflammation; Injections, Intraperitoneal; Male; Neuropeptides; Neurotransmitter Agents; Pain Threshold; Physical Stimulation; Rats; Rats, Wistar; Reaction Time; Substance P; Touch; Trigeminal Caudal Nucleus; Vibrissae | 2010 |
Central sensitization in the trigeminal nucleus caudalis produced by a conjugate of substance P and the A subunit of cholera toxin.
Topics: Animals; Behavior, Animal; Blotting, Western; Cholera Toxin; Cisterna Magna; Conditioning, Operant; Dose-Response Relationship, Drug; Facial Pain; Female; Immunohistochemistry; Injections; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Pain Measurement; Rats; Rats, Hairless; Rats, Sprague-Dawley; Receptors, Opioid, mu; Substance P; Trigeminal Caudal Nucleus | 2010 |
Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients.
Topics: Adult; Calcitonin Gene-Related Peptide; Case-Control Studies; Chronic Disease; Facial Pain; Female; Humans; Male; Migraine Disorders; Nerve Growth Factor; Neuropeptides; Pain Measurement; Saliva; Salivary Proteins and Peptides; Secretory Rate; Sex Factors; Substance P | 2011 |
Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.
Topics: Animals; Behavior, Animal; Cold Temperature; Constriction, Pathologic; Facial Pain; Grooming; Hot Temperature; Hyperalgesia; Inflammation; Injections; Lip; Male; Neuralgia; Neurokinin-1 Receptor Antagonists; Pain Measurement; Physical Stimulation; Rats; Rats, Wistar; Receptors, Neurokinin-1; Substance P; Tropanes | 2013 |
Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint.
Topics: Adolescent; Adult; Aged; Arthralgia; Bradykinin; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Facial Pain; Female; Humans; Inflammation Mediators; Joint Dislocations; Leukotriene B4; Male; Middle Aged; Neurotransmitter Agents; Nociceptors; Osteoarthritis; Serotonin; Statistics, Nonparametric; Substance P; Synovial Fluid; Synovitis; Temporomandibular Joint Disorders | 2002 |
Microdialysis in trigeminal ganglia.
Topics: Adenosine Triphosphate; Animals; Facial Pain; Guinea Pigs; Male; Microdialysis; Microelectrodes; Neurons, Afferent; Potassium Chloride; Radioimmunoassay; Substance P; Synaptic Transmission; Trigeminal Ganglion | 2002 |
Substance P-associated increase of intra-articular temperature and pain threshold in the arthritic TMJ.
Topics: Adult; Arthritis; Body Temperature; Facial Pain; Female; Glucocorticoids; Humans; Immunohistochemistry; Microcirculation; Neuroimmunomodulation; Pain Measurement; Pain Threshold; Paracentesis; Statistics, Nonparametric; Substance P; Synovial Fluid; Temporomandibular Joint; Temporomandibular Joint Disorders | 1998 |
[Mechanism of the modulation of pain transmission at the subnucleus caudalis of the trigeminal sensory nuclear complex in rabbits].
Topics: Afferent Pathways; Animals; Dental Pulp; Electric Stimulation; Enkephalins; Facial Pain; Incisor; Mandible; Rabbits; Raphe Nuclei; Serotonin; Substance P; Synaptic Transmission; Toothache; Trigeminal Caudal Nucleus | 1990 |